A New Era in Pain Management: CELL Technologies Pursues Groundbreaking Stem Cell Therapy Approval
![illustration of man dealing with back pain](https://nationalstemcelltherapy.com/wp-content/uploads/2023/04/illustration-of-man-dealing-with-back-pain-1024x683.png)
CELL Technologies Inc. has submitted clinical data from its stem cell program for pain management to Health Canada for approval. This follows a regulatory meeting on March 31st, 2023, and if approved, CELL would become the first regulatory-approved stem cell provider in North America. The data submitted covers three studies in arthritis, degenerative disc disease, […]